No claims are made or implied regarding therapeutic, metabolic, or health-related outcomes
SUSTAIN 4: A 30-week, randomized, open-label, active-controlled trial in 1089 insulin-nave adult patients on metformin sulfonylurea with type 2 diabetes comparing Ozempic injection 0.5 mg and Ozempic injection 1 mg with Lantus
Glutathione is studied here as a reference compound for redox biochemistry, antioxidant pathway research, and comparative chemistry of natural sulfur-containing peptides
The dual-receptor mechanism of this research combination is one of the most clearly characterised synergistic GH secretagogue systems in the published literature, with each component contributing a mechanistically distinct and non-redundant intracellular signal
All handling, storage, and experimental use must comply with applicable laboratory safety protocols and regulatory guidelines